This once weekly subcutaneous injection is specifically indicated for chronic weight management in adults with BMI 30 kg/m or 27 kg/m with at least one weight related condition
The oral formulation may have different absorption characteristics that influence gastrointestinal tolerability. Saxenda (Liraglutide): Shows a 13% reduction in gastric emptying at the 1-hour mark with lower doses compared to semaglutide, potentially causing fewer burping issues Dose adjustments: Working with your healthcare provider to find the optimal dose that balances efficacy with tolerability can help manage side effects Other medications in the GLP-1 class may have different side effect profiles, and your healthcare provider can help determine the best option based on your individual response and health goals
Read our doctors guide on the safety differences between compounds and FDA-approved Zepboundand why the end of the shortage changes your options
Pharmacological enhancers of autophagy such as rapamycin and metformin, act broadly on this system, while more targeted strategies, such as urolithin A to stimulate mitophagy, are under active investigation [256, 257]
The trials primary endpoint was noninferiority in HbA1c change at 1 year with orforglipron compared with oral semaglutide